← All Harmony Biosciences Holdings, INC filings

Harmony Biosciences Holdings, INC Form 4 insider transactions

NASDAQ
HRMY
Harmony Biosciences Holdings, INC
Form 4: Harmony Biosciences Director Linda Szyper Acquires Stock Options
Director Linda Szyper acquired stock options in Harmony Biosciences Holdings, Inc. on May 29, 2024.
NASDAQ
HRMY
Harmony Biosciences Holdings, INC
Form 4: Harmony Biosciences Director Acquires Stock Options
Director Peter Anastasiou acquired 6,336 stock options in Harmony Biosciences Holdings, Inc. on May 29, 2024.
NASDAQ
HRMY
Harmony Biosciences Holdings, INC
Form 4: Harmony Biosciences Holdings Exec Budur Receives Stock Options and Restricted Stock Units
Chief Medical Officer Kumar Budur of Harmony Biosciences Holdings received stock options and restricted stock units on May 1, 2024, according to a recent SEC filing.
NASDAQ
HRMY
Harmony Biosciences Holdings, INC
Form 4: Harmony Biosciences CFO Sandip Kapadia Reports Stock Transactions
Sandip Kapadia, CFO of Harmony Biosciences Holdings, Inc., reports the vesting and subsequent tax withholding of shares related to restricted stock units.
NASDAQ
HRMY
Harmony Biosciences Holdings, INC
Form 4: Harmony Biosciences Executive Dierks Sells Shares Under 10b5-1 Plan
Jeffrey Dierks, Chief Commercial Officer of Harmony Biosciences Holdings, Inc., sold 11,979 shares of common stock on March 15, 2024, under a pre-arranged 10b5-1 trading plan.
NASDAQ
HRMY
Harmony Biosciences Holdings, INC
Form 4: Harmony Biosciences Executive Dierks Exercises Options and Sells Shares
Jeffrey Dierks, Chief Commercial Officer of Harmony Biosciences Holdings, exercised stock options and sold a small portion of the acquired shares on March 8, 2024.